Launched in August 2016, the Michigan Alzheimer’s Disease Research Center (MADRC) is a partnership between Michigan State University, the University of Michigan and Wayne State University to facilitate the most advanced dementia research. As a statewide center supporting researchers and clinicians from the URC to enhance the understanding and treatment of Alzheimer’s disease and related dementias, the MADRC is one of 32 NIH-funded Alzheimer’s disease centers across the nation, and the only one that links three major research universities.
Over 5 million Americans 65 and older have Alzheimer’s disease, and another several million have other forms of dementia including frontotemporal dementia, Lewy Body dementia and vascular dementia. Currently, no disease-slowing therapies exist for any dementia. In the next five years, the ADCC will support a wide range of studies on Alzheimer’s disease and other dementias while also educating scientists, health care professionals and the public on the causes and treatment of dementias.
To learn more about the Michigan ADCC, visit alzheimers.med.umich.edu.